Reproductive risks and fertility preservation in women treated with radioactive iodine therapy for thyroid cancer
Reproductive BioMedicine Online · 2026-08 · 53 (2) · 105744
DOI: 10.1016/j.rbmo.2026.105744 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Reproductive BioMedicine Online, 2026-08. Verfasst von Fatih Aktoz und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Memorial Bahcelievler Hospital, Istanbul, Turkey. Electronic address: fatihaktoz@gmail.com. Hauptthemen laut MEDLINE: Thyroid Neoplasms, Fertility Preservation, Iodine Radioisotopes. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 60 Literaturangaben.
Abstract (Originalsprache)
Radioactive iodine (RAI) therapy is widely used after thyroidectomy in differentiated thyroid cancer. As most of these patients are young women, the potential effects of RAI on reproductive health are of clinical importance. Several studies show menstrual irregularities, transient amenorrhoea and early menopause in women with thyroid cancer. Emerging evidence shows that RAI therapy is associated with a decline in anti-Müllerian hormone levels. As reproductive safety of RAI therapy has not been proven, it is debatable whether proactive fertility preservation should be offered before RAI exposure to safeguard reproductive autonomy. This narrative review summarizes the current evidence on the reproductive risks associated with RAI therapy, and the strengths, weaknesses, opportunities, and threats analysis evaluates the rationale for fertility preservation. The goal is to review benefits versus risks, areas of uncertainty and prospects for future research to support evidence-based counselling and decision-making in women of reproductive age who are candidates for RAI therapy for thyroid cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Memorial Bahcelievler Hospital, Istanbul, Turkey. Electronic address: fatihaktoz@gmail.com.
- Department of Obstetrics and Gynecology, Hacettepe University, Ankara, Turkey.
- Department of Obstetrics and Gynecology, Basaksehir Cam and Sakura City Hospital, Istanbul, Turkey.
- Department of Nuclear Medicine, Koc University, Istanbul, Turkey; Department of Nuclear Medicine, American Hospital, Istanbul, Turkey.
- Department of Obstetrics and Gynecology, Koc University, Istanbul, Turkey; Women's Health Center, American Hospital, Istanbul, Turkey.
Zitieren
APA
Aktoz, F., Gunes, A. C., Tercan, C., Demirkol, M. O., & Yakin, K. (2026). Reproductive risks and fertility preservation in women treated with radioactive iodine therapy for thyroid cancer. Reproductive BioMedicine Online, 53(2), 105744. https://doi.org/10.1016/j.rbmo.2026.105744
Vancouver
Aktoz F, Gunes AC, Tercan C, Demirkol MO, Yakin K. Reproductive risks and fertility preservation in women treated with radioactive iodine therapy for thyroid cancer. Reproductive BioMedicine Online. 2026;53(2):105744. doi:10.1016/j.rbmo.2026.105744
BibTeX
@article{Aktoz2026,
author = {Aktoz, Fatih and Gunes, Ali Can and Tercan, Can and Demirkol, Mehmet Onur and Yakin, Kayhan},
title = {Reproductive risks and fertility preservation in women treated with radioactive iodine therapy for thyroid cancer},
journal = {Reproductive BioMedicine Online},
year = {2026},
volume = {53},
number = {2},
pages = {105744},
doi = {10.1016/j.rbmo.2026.105744}
}
EUVIMED